AGGRASTAT Israel - English - Ministry of Health

aggrastat

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate - solution for infusion - tirofiban as hydrochloride monohydrate 0.05 mg/ml - tirofiban - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

AGGRASTAT Israel - English - Ministry of Health

aggrastat

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate 0.25 mg/ml - solution for infusion - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

Aggrastat (250mcg/ml) concentrate for solution for infusion Malta - English - Medicines Authority

aggrastat (250mcg/ml) concentrate for solution for infusion

correvio (uk) limited - tirofiban - concentrate for solution for infusion - tirofiban 4 µg/ml - antithrombotic agents

Aggrastat 50mcg/ml Solution for Infusion Malta - English - Medicines Authority

aggrastat 50mcg/ml solution for infusion

correvio (uk) limited - tirofiban hydrochloride monohydrate 50 µg/ml - solution for infusion

AGGRASTAT LIQUID Canada - English - Health Canada

aggrastat liquid

correvio (uk) ltd - tirofiban (tirofiban hydrochloride) - liquid - 0.25mg - tirofiban (tirofiban hydrochloride) 0.25mg - platelet aggregation inhibitors

AGGRASTAT SOLUTION Canada - English - Health Canada

aggrastat solution

cipher pharmaceuticals inc - tirofiban (tirofiban hydrochloride) - solution - 12.5mg - tirofiban (tirofiban hydrochloride) 12.5mg - platelet aggregation inhibitors

Tirofiban 50 micrograms/ml solution for infusion Malta - English - Medicines Authority

tirofiban 50 micrograms/ml solution for infusion

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - tirofiban - solution for infusion - tirofiban 50 µg/ml - antithrombotic agents

Aggrastat 0,25 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aggrastat 0,25 mg/ml inf. sol. (conc.) i.v. vial

correvio - tirofiban hydrochloride 281 µg/ml - eq. tirofiban 250 µg/ml - concentrate for solution for infusion - 0,25 mg/ml - tirofiban hydrochloride 281 µg/ml - tirofiban

Aggrastat 0,05 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aggrastat 0,05 mg/ml inf. sol. i.v.

correvio - tirofiban hydrochloride 56,18 µg/ml - eq. tirofiban 50 µg/ml - solution for infusion - 0,05 mg/ml - tirofiban hydrochloride 56.18 µg/ml - tirofiban

Aggrastat Concentrate for Soln for Inf 250mcg/ml Malta - English - Medicines Authority

aggrastat concentrate for soln for inf 250mcg/ml

correvio 15 rue du bicentenaire, 92800 puteaux, france - tirofiban - concentrate for solution for infusion - tirofiban 250 µg/ml - antithrombotic agents